Shonda A. Foster
About
Shonda A. Foster is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine.
According to data from OpenAlex, Shonda A. Foster has authored 41 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Shonda A. Foster's work include Migraine and Headache Studies (12 papers), Psychosomatic Disorders and Their Treatments (9 papers) and Trigeminal Neuralgia and Treatments (7 papers). Shonda A. Foster is often cited by papers focused on Migraine and Headache Studies (12 papers), Psychosomatic Disorders and Their Treatments (9 papers) and Trigeminal Neuralgia and Treatments (7 papers). Shonda A. Foster collaborates with scholars based in United States, United Kingdom and Australia. Shonda A. Foster's co-authors include S. Al Sawah, Baojin Zhu, Eric S. Meadows, Noriko Iikuni, Russel Burge, Xiang Zhang, Laurence S. Magder, Janet H. Ford, Kathleen A. Foley and Scott J. Leischow and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Medical Care.
In The Last Decade
Shonda A. Foster
41 papers receiving 760 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shonda A. Foster United States | 18 | 197 | 191 | 158 | 141 | 138 | 41 | 782 | ||
| Ihsane Hmamouchi Morocco | 20 | 503 2.6× | 176 0.9× | 89 0.6× | 146 1.0× | 117 0.8× | 84 | 1.1k | ||
| Ricardo J O Ferreira Portugal | 15 | 634 3.2× | 102 0.5× | 82 0.5× | 167 1.2× | 106 0.8× | 67 | 1.0k | ||
| J. W. G. Jacobs Netherlands | 20 | 735 3.7× | 105 0.5× | 64 0.4× | 120 0.9× | 160 1.2× | 38 | 1.2k | ||
| Sofia Pedro United States | 16 | 488 2.5× | 111 0.6× | 119 0.8× | 77 0.5× | 33 0.2× | 38 | 954 | ||
| Jonathan Graf United States | 21 | 626 3.2× | 168 0.9× | 56 0.4× | 144 1.0× | 62 0.4× | 42 | 1.3k | ||
| Isabel Castrejón Spain | 22 | 1.0k 5.1× | 216 1.1× | 192 1.2× | 179 1.3× | 31 0.2× | 138 | 1.6k | ||
| Kelly Hollis United States | 17 | 269 1.4× | 85 0.4× | 101 0.6× | 118 0.8× | 24 0.2× | 39 | 976 | ||
| Tom O’Dwyer Ireland | 15 | 669 3.4× | 356 1.9× | 100 0.6× | 89 0.6× | 85 0.6× | 24 | 1.1k | ||
| Ho Yin Chung Hong Kong | 15 | 609 3.1× | 309 1.6× | 56 0.4× | 50 0.4× | 138 1.0× | 67 | 1.0k | ||
| Marcus Köller Austria | 16 | 304 1.5× | 234 1.2× | 24 0.2× | 65 0.5× | 40 0.3× | 38 | 857 |
Countries citing papers authored by Shonda A. Foster
Since
Specialization
Citations
This map shows the geographic impact of Shonda A. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shonda A. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shonda A. Foster more than expected).
Fields of papers citing papers by Shonda A. Foster
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shonda A. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shonda A. Foster. The network helps show where Shonda A. Foster may publish in the future.
Co-authorship network of co-authors of Shonda A. Foster
This figure shows the co-authorship network connecting the top 25 collaborators of Shonda A. Foster. A scholar is included among the top collaborators of Shonda A. Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shonda A. Foster. Shonda A. Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ford, Janet H., Russell Nichols, Shonda A. Foster, et al.. (2022). Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN). Journal of Medical Economics. 25(1). 1030–1038.
2.
Citrome, Leslie, Margarita Sánchez del Río, Yanhong Dong, et al.. (2021). Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm. Advances in Therapy. 38(8). 4442–4460.
3.
Foster, Shonda A., et al.. (2020). Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study. Current Medical Research and Opinion. 37(3). 443–457.
4.
Ford, Janet H., Shonda A. Foster, Russell Nichols, et al.. (2020). A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe. Journal of Patient-Reported Outcomes. 4(1). 53–53.
5.
Gilligan, Adrienne M., et al.. (2018). Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine. Journal of Occupational and Environmental Medicine. 60(12). 1120–1127.
6.
Ford, Janet H., Krista Schroeder, Allen W. Nyhuis, Shonda A. Foster, & Sheena K. Aurora. (2018). Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs. Journal of Managed Care & Specialty Pharmacy. 25(1). 46–59.
7.
Armstrong, April W., Shonda A. Foster, Brian S. Comer, et al.. (2018). Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization. BMC Dermatology. 18(1). 4–4.
8.
Ford, Janet H., Shonda A. Foster, Virginia L. Stauffer, et al.. (2018). Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine. Patient Preference and Adherence. Volume 12. 2413–2424.
9.
Sawah, S. Al, Shonda A. Foster, Orin M. Goldblum, et al.. (2017). Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis. Journal of Medical Economics. 20(9). 982–990.
10.
Foster, Shonda A., Baojin Zhu, Jiaying Guo, et al.. (2016). Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis. Journal of Managed Care & Specialty Pharmacy. 22(4). 396–405.
11.
Sawah, S. Al, Shonda A. Foster, April N. Naegeli, et al.. (2015). FRI0420 Health Related Quality of Life in Lupus Differs by How Patients Perceive their Health and How Often They Experience Flares: Findings from a Cross-Sectional Online Survey in the United States. Annals of the Rheumatic Diseases. 74. 578–579.
12.
Foster, Shonda A., Nianwen Shi, Suellen M. Curkendall, et al.. (2013). Fractures in women treated with raloxifene or alendronate: a retrospective database analysis. BMC Women s Health. 13(1). 15–15.
13.
Nojiri, Shuko, Russel Burge, Jennifer Flynn, Shonda A. Foster, & Hideaki Sowa. (2013). Osteoporosis and treatments in Japan: management for preventing subsequent fractures. Journal of Bone and Mineral Metabolism. 31(4). 367–380.
14.
Hazel‐Fernandez, Leslie, et al.. (2013). Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study. BMC Musculoskeletal Disorders. 14(1). 4–4.
15.
Kaltenboeck, Anna, Shonda A. Foster, Jasmina Ivanova, et al.. (2012). The Direct and Indirect Costs among U.S. Privately Insured Employees with Hypogonadism. The Journal of Sexual Medicine. 9(9). 2438–2447.
16.
Juneja, Rattan, et al.. (2010). The Nuts and Bolts of Subcutaneous Insulin Therapy in Non-Critical Care Hospital Settings. Postgraduate Medicine. 122(1). 153–162.
17.
Foley, Kathleen A., Shonda A. Foster, Eric S. Meadows, Onur Baser, & Stacey R. Long. (2007). Assessment of the Clinical Management of Fragility Fractures and Implications for the New HEDIS Osteoporosis Measure. Medical Care. 45(9). 902–906.
18.
Foster, Shonda A., et al.. (2007). Characteristics of patients initiating teriparatide for the treatment of osteoporosis. Osteoporosis International. 19(3). 373–377.
19.
Shaw, James W., Stephen Joel Coons, Shonda A. Foster, Scott J. Leischow, & Ron D. Hays. (2001). Responsiveness of the smoking cessation quality of life (SCQoL) questionnaire. Clinical Therapeutics. 23(6). 957–969.
20.
Olufade, Abayomi O., James W. Shaw, Shonda A. Foster, et al.. (1999). Development of the Smoking Cessation quality of life questionnaire. Clinical Therapeutics. 21(12). 2113–2130.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ihsane Hmamouchi Breakdown of academic impact, for papers by Ricardo J O Ferreira Breakdown of academic impact, for papers by J. W. G. Jacobs Breakdown of academic impact, for papers by Sofia Pedro Breakdown of academic impact, for papers by Jonathan Graf Breakdown of academic impact, for papers by Isabel Castrejón Breakdown of academic impact, for papers by Kelly Hollis Breakdown of academic impact, for papers by Tom O’Dwyer Breakdown of academic impact, for papers by Ho Yin Chung Breakdown of academic impact, for papers by Marcus Köller